Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.
Nagaileben Co's Sloan Ratio for the quarter that ended in Feb. 2026 was 0.00%.
As of Feb. 2026, Nagaileben Co has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.
Nagaileben Co (TSE:7447) Sloan Ratio % Explanation
A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.
If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.
If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.
If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.
As of Feb. 2026, Nagaileben Co has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.
Nagaileben Co Sloan Ratio % Related Terms
Nagaileben Co Sloan Ratio % Historical Data
* Premium members only.
The historical data trend for Nagaileben Co's Sloan Ratio % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7447 vs RL, LEVI, VFC: Sloan Ratio % Comparison
For the Apparel Manufacturing subindustry, Nagaileben Co's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nagaileben Co Sloan Ratio % vs Manufacturing - Apparel & Accessories Industry
For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, Nagaileben Co's Sloan Ratio % distribution charts can be found below:
* The bar in red indicates where Nagaileben Co's Sloan Ratio % falls into.
Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.
Nagaileben Co's Sloan Ratio for the fiscal year that ended in Aug. 2025 is calculated as
Nagaileben Co's Net Income for the trailing twelve months (TTM) ended in Feb. 2026 was 1003.995 (May. 2025 ) + 506.995 (Aug. 2025 ) + 317.527 (Nov. 2025 ) + 696.863 (Feb. 2026 ) = 円2,525 Mil.
Nagaileben Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Feb. 2026 was 0 (May. 2025 ) + 0 (Aug. 2025 ) + 0 (Nov. 2025 ) + 0 (Feb. 2026 ) = 円0 Mil.
Nagaileben Co's Cash Flow from Investing for the trailing twelve months (TTM) ended in Feb. 2026 was 0 (May. 2025 ) + 0 (Aug. 2025 ) + 0 (Nov. 2025 ) + 0 (Feb. 2026 ) = 円0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nagaileben Co (TSE:7447) has a Sloan Ratio % of 0.00% as of Feb. 2026. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Nagaileben Co and its competitors.
Is Nagaileben Co's Sloan Ratio % too high?
Nagaileben Co's current Sloan Ratio % is 0.00%. Overall, Nagaileben Co has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nagaileben Co's Sloan Ratio % compare to RL and LEVI?
Nagaileben Co's Sloan Ratio % of 0.00% can be compared against companies in the Manufacturing - Apparel & Accessories industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Sloan Ratio % for a Manufacturing - Apparel & Accessories company?
A good Sloan Ratio % depends on the Manufacturing - Apparel & Accessories industry context. However, Sloan Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Sloan Ratio % mean?
A high Sloan Ratio % can signal that a stock is expensive relative to its fundamentals. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Nagaileben Co and its competitors. Nagaileben Co's current Sloan Ratio % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nagaileben Co stock overvalued right now?
Based on GuruFocus' analysis, Nagaileben Co (TSE:7447) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,272.22, compared to a current price of 円1,690.00 — trading 25.6% below its estimated fair value. The current Sloan Ratio % is 0.00%. Nagaileben Co's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Sloan Ratio % calculated?
Sloan Ratio % is calculated from a company's financial statements. For Nagaileben Co (TSE:7447), the current Sloan Ratio % is 0.00% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nagaileben Co (TSE:7447) Overvalued in 2026?
Based on GuruFocus' analysis, Nagaileben Co stock appears to be undervalued.
The current stock price of 円1,690.00 is trading 25.6% below its estimated GF Value™ of 円2,272.22.
GuruFocus considers Nagaileben Co to be Modestly Undervalued.
Key valuation signals for TSE:7447:
Sloan Ratio %: 0.00%
GF Value™: 円2,272.22 vs. price of 円1,690.00 (25.6% below fair value)
No single metric tells the full story. See the TSE:7447 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nagaileben Co Ltd manufactures and sells medical clothing and shoes for doctors, dentists, pharmacists, nursing staff, patients, and care workers. Nearly all the company's sales are in Japan, with more than half of total sales in east Japan and the remaining Japanese sales in central Japan and west Japan. The company's six item segments are healthcare wear, surgery wear, doctor wear, utility wear, patient wear, and shoes. Healthcare wear accounts for more than half of total company revenue. Doctors' wear, patient wear, and surgery wear constitute most of the remaining revenue. The company manufactures its products in Japan and Indonesia.
66GF Score
Get the complete analysis for TSE:7447
Sloan Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7447 has been successfully added to your 
